Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis

Neuroscience and Biobehavioral Reviews

Volumn 67, Issue , 2016, Pages 137-146

  Ramien, Caren ^a   Taenzer, Aline ^b   Lupu, Andreea ^a,c   Heckmann, Nina ^a   Engler, Jan Broder ^a   Patas, Kostas ^a   Friese, Manuel A ^a   Gold, Stefan M ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

Autoimmune disease; Epigenetics; Experimental autoimmune encephalomyelitis; Gene environment interaction; Inflammation; Multiple sclerosis; Neurodegeneration; Risk factors; Sex bias; Sex chromosomes; Sex hormones

Indexed keywords

DISEASE ACTIVITY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; EPIGENETICS; GENETIC REGULATION; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INHERITANCE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; ANIMAL; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; FEMALE; MALE; SEXUAL DEVELOPMENT;

ANIMALS; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; PREGNANCY; SEX CHARACTERISTICS;

EID: 84955293447     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.12.015     Document Type: Review

References (95)

1. Acaz-Fonseca, E., Sanchez-Gonzalez, R., Azcoitia, I., Arevalo, M.A., Garcia-Segura, L.M., Role of astrocytes in the neuroprotective actions of 17β-estradiol and selective estrogen receptor modulators. Mol. Cell. Endocrinol. 389 (2014), 48–57, 10.1016/j.mce.2014.01.009.
2. Alonso, A., Clark, C.J., Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence. J. Neurol. Sci. 286 (2009), 73–75, 10.1016/j.jns.2009.04.038.
3. Alonso, A., Herna, M.A., Temporal trends in the incidence of multiple sclerosis. Neurology 71 (2008), 129–135, 10.1212/01.wnl.0000316802.35974.34.
4. Arevalo, M.A., Azcoitia, I., Garcia-Segura, L.M., The neuroprotective actions of oestradiol and oestrogen receptors. Nat. Rev. Neurosci. 16 (2015), 17–29, 10.1038/nrn3856.
5. Arevalo, M.A., Santos-Galindo, M., Bellini, M.J., Azcoitia, I., Garcia-Segura, L.M., Actions of estrogens on glial cells: implications for neuroprotection. Biochim. Biophys. Acta—Gen. Subj., 1800, 1106–1112, 10.1016/j.bbagen.2009.10.002.
6. Bodhankar, S., Vandenbark, A.A., Offner, H., Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells. Immunology 137 (2012), 282–293, 10.1111/imm.12013.
7. Cahill, L., Why sex matters for neuroscience. Nat. Rev. Neurosci. 7 (2006), 477–484, 10.1038/nrn1909.
8. Caruso, D., D'Intino, G., Giatti, S., Maschi, O., Pesaresi, M., Calabrese, D., Garcia-Segura, L.M., Calza, L., Melcangi, R.C., Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis. J. Neurochem. 114 (2010), 921–932, 10.1111/j. 1471-4159.2010.06825.x.
9. Case, L.K., Teuscher, C., 2015. Y genetic variation and phenotypic diversity in health and disease. Biology of sex differences 6. 10.1186/s13293-015-0024-z.
10. Case, L.K., Wall, E.H., Dragon, J.A., Saligrama, N., Krementsov, D.N., Moussawi, M., Zachary, J.F., Huber, S.A., Blankenhorn, E.P., Teuscher, C., The y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease. Genome Res. 23 (2013), 1474–1485, 10.1101/gr.156703.113.
11. Case, L.K., Wall, E.H., Osmanski, E.E., Dragon, J.A., Saligrama, N., Zachary, J.F., Lemos, B., Blankenhorn, E.P., Teuscher, C., 2015. Copy number variation in Y chromosome multicopy genes is linked to a paternal parent-of-origin effect on CNS autoimmune disease in female offspring. Genome biology 16. 10.1186/s13059-015-0591-7.
12. Confavreux, C., Hutchinson, M., Hours, M.M., Cortinovis-Tourniaire, P., Moreau, T., Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N. Engl. J. Med. 339 (1998), 285–291, 10.1056/NEJM199807303390501.
13. Crawford, D.K., Mangiardi, M., Song, B., Patel, R., Du, S., Sofroniew, M.V., Voskuhl, R.R., Tiwari-Woodruff, S.K., Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 133 (2010), 2999–3016, 10.1093/brain/awq237.
14. Dalal, M., Kim, S., Voskuhl, R.R., Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159 (1997), 3–6.
15. Du, S., Itoh, N., Askarinam, S., Hill, H., Arnold, A.P., Voskuhl, R.R., XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 2806–2811, 10.1073/pnas.1307091111.
16. Du, S., Sandoval, F., Trinh, P., Umeda, E., Voskuhl, R.R., Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease. Eur. J. Immunol. 41 (2011), 140–150, 10.1002/eji.201040796.
17. Dunn, S.E., Bhat, R., Straus, D.S., Sobel, R.A., Axtell, R., Johnson, A., Nguyen, K., Mukundan, L., Moshkova, M., Dugas, J.C., Chawla, A., Steinman, L., Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J. Exp. Med. 207 (2010), 1599–1608, 10.1084/jem.20091663.
18. Dunn, S.E., Gunde, E., Lee, H., Sex-based differences in multiple sclerosis (MS): part II: rising incidence of multiple sclerosis in women and the vulnerability of men to progression of this disease. Curr. Top. Behav. Neurosci., 2015, 10.1007/7854_2015_370.
19. Dunn, S.E., Ousman, S.S., Sobel, R.A., Zuniga, L., Baranzini, S.E., Youssef, S., Crowell, A., Loh, J., Oksenberg, J., Steinman, L., Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J. Exp. Med. 204 (2007), 321–330, 10.1084/jem.20061839.
20. El-Etr, M., Rame, M., Boucher, C., Ghoumari, A.M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., Sitruk-Ware, R., Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. Glia 63 (2015), 104–117, 10.1002/glia.22736.
21. Erlebacher, A., Mechanisms of T cell tolerance towards the allogeneic fetus. Nat. Rev. Immunol. 13 (2013), 23–33, 10.1038/nri3361.
22. Finkelsztejn, A., Brooks, J.B., Paschoal, F.M.J., Fragoso, Y.D., What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG: Int. J. Obstet. Gynaecol. 118 (2011), 790–797, 10.1111/j. 1471-0528.2011.02931.x.
23. Fish, E.N., The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 8 (2008), 737–744, 10.1038/nri2394.
24. Frischer, J.M., Weigand, S.D., Guo, Y., Kale, N., Parisi, J.E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., Lassmann, H., Lucchinetti, C.F., Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann. Neurol. 78 (2015), 710–721, 10.1002/ana.24497.
25. Garay, L., Gonzalez Deniselle, M.C., Sitruk-Ware, R., Guennoun, R., Schumacher, M., De Nicola, A.F., Efficacy of the selective progesterone receptor agonist nestorone for chronic experimental autoimmune encephalomyelitis. J. Neuroimmunol. 276 (2014), 89–97, 10.1016/j.jneuroim.2014.08.619.
26. Garidou, L., Laffont, S., Douin-Echinard, V., Coureau, C., Krust, A., Chambon, P., Guery, J.-C., Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004), 2435–2442, 10.4049/jimmunol.173.4.2435.
27. Ghisletti, S., Meda, C., Maggi, A., Vegeto, E., 17beta-estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization. Mol. Cell. Biol. 25 (2005), 2957–2968, 10.1128/MCB.25.8.2957.
28. Giatti, S., Rigolio, R., Romano, S., Mitro, N., Viviani, B., Cavaletti, G., Caruso, D., Garcia-Segura, L.M., Melcangi, R.C., Dihydrotestosterone as a protective agent in chronic experimental autoimmune encephalomyelitis. Neuroendocrinology, 2015, 10.1159/000381064.
29. Gold, S.M., Chalifoux, S., Giesser, B.S., Voskuhl, R.R., Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone. J. Neuroinflammation, 5, 2008, 32, 10.1186/1742-2094-5-32.
30. Gold, S.M., Sasidhar, M.V., Morales, L.B., Du, S., Sicotte, N.L., Tiwari-Woodruff, S.K., Voskuhl, R.R., Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha). Lab. Invest. J. Tech. Methods Pathol. 89 (2009), 1076–1083, 10.1038/labinvest.2009.79.
31. Holmqvist, P., Hammar, M., Landtblom, A.-M., Brynhildsen, J., Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil. Steril. 94 (2010), 2835–2837, 10.1016/j.fertnstert.2010.06.045.
32. Hussain, R., Ghoumari, A.M., Bielecki, B., Steibel, J., Boehm, N., Liere, P., Macklin, W.B., Kumar, N., Habert, R., Mhaouty-Kodja, S., Tronche, F., Sitruk-Ware, R., Schumacher, M., Ghandour, M.S., The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. Brain 136 (2013), 132–146, 10.1093/brain/aws284.
33. Johann, S., Beyer, C., Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J. Steroid Biochem. Mol. Biol. 137 (2013), 71–81, 10.1016/j.jsbmb.2012.11.006.
34. Kalaitzidis, D., Gilmore, T.D., Transcription factor cross-talk: the estrogen receptor and NF-κB. Trends Endocrinol. Metab. 16 (2005), 46–52, 10.1016/j.tem.2005.01.004.
35. Kalincik, T., Vivek, V., Jokubaitis, V., Lechner-Scott, J., Trojano, M., Izquierdo, G., Lugaresi, A., Grand'maison, F., Hupperts, R., Oreja-Guevara, C., Bergamaschi, R., Iuliano, G., Alroughani, R., Van Pesch, V., Amato, M.P., Slee, M., Verheul, F., Fernandez-Bolanos, R., Fiol, M., Spitaleri, D., La, Cristiano, E., Gray, O., Cabrera-Gomez, J.A., Shaygannejad, V., Herbert, J., Vucic, S., Needham, M., Petkovska-Boskova, T., Sirbu, C.-A., Duquette, P., Girard, M., Grammond, P., Boz, C., Giuliani, G., Rio, M.E., Barnett, M., Flechter, S., Moore, F., Singhal, B., Bacile, E.A., Saladino, M.L., Shaw, C., Skromne, E., Poehlau, D., Vella, N., Spelman, T., Liew, D., Kilpatrick, T.J., Butzkueven, H., Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain 136 (2013), 3609–3617, 10.1093/brain/awt281.
36. Khalaj, A.J., Yoon, J., Nakai, J., Winchester, Z., Moore, S.M., Yoo, T., Martinez-Torres, L., Kumar, S., Itoh, N., Tiwari-Woodruff, S.K., Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 19125–19130, 10.1073/pnas.1311763110.
37. Kido, T., Lau, Y.-F.C., Roles of the Y chromosome genes in human cancers. Asian J. Androl. 17 (2015), 373–380, 10.4103/1008-682X.150842.
38. Kissick, H.T., Sanda, M.G., Dunn, L.K., Pellegrini, K.L., On, S.T., Noel, J.K., Arredouani, M.S., Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 9887–9892, 10.1073/pnas.1402468111.
39. Koch-Henriksen, N., Sørensen, P.S., The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 9 (2010), 520–532, 10.1016/S1474-4422(10)70064-8.
40. Kovats, S., Estrogen receptors regulate innate immune cells and signaling pathways. Cell. Immunol. 294 (2015), 63–69, 10.1016/j.cellimm.2015.01.018.
41. Kurth, F., Luders, E., Sicotte, N.L., Gaser, C., Giesser, B.S., Swerdloff, R.S., Montag, M.J., Voskuhl, R.R., Mackenzie-Graham, A., Neuroprotective effects of testosterone treatment in men with multiple sclerosis. NeuroImage Clin. 4 (2014), 454–460, 10.1016/j.nicl.2014.03.001.
42. Laffont, S., Garnier, L., Lélu, K., Guéry, J.-C., Estrogen-mediated protection of experimental autoimmune encephalomyelitis: lessons from the dissection of estrogen receptor-signaling in vivo. Biomed. J. 38 (2015), 194–205, 10.4103/2319-4170.158509.
43. Lai, J.-J., Lai, K.-P., Zeng, W., Chuang, K.-H., Altuwaijri, S., Chang, C., Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice. Am. J. Pathol. 181 (2012), 1504–1512, 10.1016/j.ajpath.2012.07.008.
44. Lehmann, S.M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., Habbel, P., Kälin, R., Franzoni, E., Rybak, A., Nguyen, D., Veh, R., Ninnemann, O., Peters, O., Nitsch, R., Heppner, F.L., Golenbock, D., Schott, E., Ploegh, H.L., Wulczyn, F.G., Lehnardt, S., An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15 (2012), 827–835, 10.1038/nn.3113.
45. Lélu, K., Laffont, S., Delpy, L., Paulet, P.-E., Périnat, T., Tschanz, S.A., Pelletier, L., Engelhardt, B., Guéry, J.-C., Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J. Immunol. 187 (2011), 2386–2393, 10.4049/jimmunol.1101578.
46. Levin, E.R., G protein-coupled receptor 30: estrogen receptor or collaborator?. Endocrinology 150 (2009), 1563–1565, 10.1210/en.2008-1759.
47. Libert, C., Dejager, L., Pinheiro, I., The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 10 (2010), 594–604, 10.1038/nri2815.
48. Luchetti, S., van Eden, C.G., Schuurman, K., van Strien, M.E., Swaab, D.F., Huitinga, I., Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions. J. Neuropathol. Exp. Neurol. 73 (2014), 123–135, 10.1097/NEN.0000000000000037.
49. Luders, E., Gaser, C., Narr, K.L., Toga, A.W., Why sex matters: brain size independent differences in gray matter distributions between men and women. J. Neurosci. 29 (2009), 14265–14270, 10.1523/JNEUROSCI. 2261-09.2009.
50. Markle, J.G., Fish, E.N., Sex matters in immunity. Trends Immunol. 35 (2014), 97–104, 10.1016/j.it.2013.10.006.
51. Matejuk, A., Hopke, C., Vandenbark, A.A., Hurn, P.D., Offner, H., Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J. Immunol. 174 (2005), 2387–2395, 10.4049/jimmunol.174.4.2387.
52. McCarthy, M.M., Arnold, A.P., Ball, G.F., Blaustein, J.D., De Vries, G.J., Sex differences in the brain: the not so inconvenient truth. J. Neurosci. 32 (2012), 2241–2247, 10.1523/JNEUROSCI. 5372-11.2012.
53. Moore, S., Patel, R., Hannsun, G., Yang, J., Tiwari-Woodruff, S.K., Sex chromosome complement influences functional callosal myelination. Neuroscience 245 (2013), 166–178, 10.1016/j.neuroscience.2013.04.017.
54. Moore, S.M., Khalaj, A.J., Kumar, S., Winchester, Z., Yoon, J., Yoo, T., Martinez-Torres, L., Yasui, N., Katzenellenbogen, J.A., Tiwari-Woodruff, S.K., Multiple functional therapeutic effects of the estrogen receptor beta agonist indazole-Cl in a mouse model of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 18061–18066, 10.1073/pnas.1411294111.
55. Morales, L.B.J., Loo, K.K., Liu, H.-B., Peterson, C., Tiwari-Woodruff, S., Voskuhl, R.R., Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci. 26 (2006), 6823–6833, 10.1523/JNEUROSCI. 0453-06.2006.
56. Nadkarni, S., McArthur, S., Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity. Curr. Opin. Pharmacol. 13 (2013), 576–581, 10.1016/j.coph.2013.05.007.
57. Nashold, F.E., Spach, K.M., Spanier, J.A., Hayes, C.E., Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J. Immunol. 183 (2009), 3672–3681, 10.4049/jimmunol.0901351 (Baltimore, Md.: 1950).
58. Nguyen, D.K., Disteche, C.M., High expression of the mammalian X chromosome in brain. Brain Res. 1126 (2006), 46–49, 10.1016/j.brainres.2006.08.053.
59. Noorbakhsh, F., Baker, G.B., Power, C., Allopregnanolone and neuroinflammation: a focus on multiple sclerosis. Front. Cell. Neurosci., 8, 2014, 134, 10.3389/fncel.2014.00134.
60. Nunn, C.L., Lindenfors, P., Pursall, E.R., Rolff, J., On sexual dimorphism in immune function. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 364 (2009), 61–69, 10.1098/rstb.2008.0148.
61. Palaszynski, K.M., Liu, H., Loo, K.K., Voskuhl, R.R., Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 149 (2004), 84–89, 10.1016/j.jneuroim.2003.12.015.
62. Palaszynski, K.M., Smith, D.L., Kamrava, S., Burgoyne, P.S., Arnold, A.P., Voskuhl, R.R., A yin-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 146 (2005), 3280–3285, 10.1210/en.2005-0284.
63. Pennell, L.M., Galligan, C.L., Fish, E.N., Sex affects immunity. J. Autoimmun. 38 (2012), J282–J291, 10.1016/j.jaut.2011.11.013.
64. Pierdominici, M., Maselli, A., Colasanti, T., Giammarioli, A.M., Delunardo, F., Vacirca, D., Sanchez, M., Giovannetti, A., Malorni, W., Ortona, E., Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol. Lett. 132 (2010), 79–85, 10.1016/j.imlet.2010.06.003.
65. Polanczyk, M., Zamora, A., Subramanian, S., Matejuk, A., Hess, D.L., Blankenhorn, E.P., Teuscher, C., Vandenbark, A.A., Offner, H., The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am. J. Pathol. 163 (2003), 1599–1605.
66. Ponsonby, A.L., Lucas, R.M., Van Der Mei, I.A., Dear, K., Valery, P.C., Pender, M.P., V, Coulthard, A., Chapman, C., Williams, D., McMichael, A.J., Dwyer, T., Offspring number, pregnancy, and risk of a first clinical demyelinating event the ausimmune study. Neurology 78 (2012), 867–874, 10.1212/WNL.0b013e31824c4648.
67. Prossnitz, E.R., Arterburn, J.B., Sklar, L.A., GPR30: a G protein-coupled receptor for estrogen. Mol. Cell. Endocrinol. 265–266 (2007), 138–142, 10.1016/j.mce.2006.12.010.
68. Ruhrmann, S., Stridh, P., Kular, L., Jagodic, M., Genomic imprinting: a missing piece of the multiple sclerosis puzzle?. Int. J. Biochem. Cell Biol., 2015, 10.1016/j.biocel.2015.05.010.
69. Saijo, K., Collier, J.G., Li, A.C., Katzenellenbogen, J.A., Glass, C.K., An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145 (2011), 584–595, 10.1016/j.cell.2011.03.050.
70. Sasidhar, M.V., Itoh, N., Gold, S.M., Lawson, G.W., Voskuhl, R.R., The XX sex chromosome complement in mice is associated with increased spontaneous lupus as compared to XY. Ann. Rheum. Dis. 71 (2012), 1418–1422, 10.1136/annrheumdis-2011-201246.
71. Schneider, A.E., Kárpáti, E., Schuszter, K., Tóth, E.A., Kiss, E., Kulcsár, M., László, G., Matko, J., A dynamic network of estrogen receptors in murine lymphocytes: fine-tuning the immune response. J. Leukoc. Biol. 96 (2014), 857–872, 10.1189/jlb.2A0214-080RR.
72. Sicotte, N.L., Giesser, B.S., Tandon, V., Klutch, R., Steiner, B., Drain, A.E., Shattuck, D.W., Hull, L., Wang, H.-J., Elashoff, R.M., Swerdloff, R.S., Voskuhl, R.R., Testosterone treatment in multiple sclerosis: a pilot study. Arch. Neurol., 2007, 10.1001/archneur.64.5.683.
73. Sicotte, N.L., Liva, S.M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T.C.J., Voskuhl, R.R., Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 52 (2002), 421–428, 10.1002/ana.10301.
74. Smith-Bouvier, D.L., Divekar, A.A., Sasidhar, M., Du, S., Tiwari-Woodruff, S.K., King, J.K., Arnold, A.P., Singh, R.R., Voskuhl, R.R., A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 205 (2008), 1099–1108, 10.1084/jem.20070850.
75. Soldan, S.S., Alvarez Retuerto, A.I., Sicotte, N.L., Voskuhl, R.R., Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol., 2003, 10.4049/jimmunol.171.11.6267 (Baltimore, Md.: 1950).
76. Spach, K.M., Blake, M., Bunn, J.Y., McElvany, B., Noubade, R., Blankenhorn, E.P., Teuscher, C., Cutting edge: the Y chromosome ontrols the age-dependent experimental allergic encephalomyelitis sexual dimorphism in SJL/J mice. J. Immunol. 182 (2009), 1789–1793, 10.4049/jimmunol.0803200.
77. Spanier, J.A., Nashold, F.E., Mayne, C.G., Nelson, C.D., Hayes, C.E., Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease. J. Neuroimmunol. 286 (2015), 48–58, 10.1016/j.jneuroim.2015.06.015.
78. Spence, R.D., Hamby, M.E., Umeda, E., Itoh, N., Du, S., Wisdom, A.J., Cao, Y., Bondar, G., Lam, J., Ao, Y., Sandoval, F., Suriany, S., Sofroniew, M.V., Voskuhl, R.R., Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 8867–8872, 10.1073/pnas.1103833108.
79. Spence, R.D., Wisdom, A.J., Cao, Y., Hill, H.M., Mongerson, C.R.L., Stapornkul, B., Itoh, N., Sofroniew, M.V., Voskuhl, R.R., Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons. J. Neurosci. 33 (2013), 10924–10933, 10.1523/JNEUROSCI. 0886-13.2013.
80. Stridh, P., Ruhrmann, S., Bergman, P., Thessén Hedreul, M., Flytzani, S., Da Beyeen, A., Gillett, A., Krivosija, N., Öckinger, J., Ferguson-Smith, A.C., Jagodic, M., Parent-of-origin effects implicate epigenetic regulation of experimental autoimmune encephalomyelitis and identify imprinted Dlk1 as a novel risk gene. PLoS Genet., 10, 2014, e1004265, 10.1371/journal.pgen.1004265.
81. Teuscher, C., Noubade, R., Spach, K., McElvany, B., Bunn, J.Y., Fillmore, P.D., Zachary, J.F., Blankenhorn, E.P., Evidence that the Y chromosome influences autoimmune disease in male and female mice. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 8024–8029, 10.1073/pnas.0600536103.
82. Tiwari-Woodruff, S., Morales, L.B.J., Lee, R., Voskuhl, R.R., Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 14813–14818, 10.1073/pnas.0703783104.
83. Tiwari-Woodruff, S., Voskuhl, R.R., Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J. Neurol. Sci. 286 (2009), 81–85, 10.1016/j.jns.2009.04.023.
84. Tremlett, H., Zhao, Y., Joseph, J., Devonshire, V., UBCMS clinic neurologists. Relapses in multiple sclerosis are age- and time-dependent. J. Neurol. Neurosurg. Psychiatry 79 (2008), 1368–1374, 10.1136/jnnp.2008.145805.
85. Trigunaite, A., Dimo, J., Jørgensen, T.N., Suppressive effects of androgens on the immune system. Cell. Immunol. 294 (2015), 87–94, 10.1016/j.cellimm.2015.02.004.
86. Vincent, C.M., Gwynne, D.T., Sex-biased immunity is driven by relative differences in reproductive investment sex-biased immunity is driven by relative differences in reproductive investment. Proc. R. Soc. B: Biol. Sci., 281, 2014, 20140333, 10.1098/rspb.2014.0333.
87. Voskuhl, R.R., Wang, H., Wu, T.C.J., Sicotte, N.L., Nakamura, K., Kurth, F., Itoh, N., Bardens, J., Bernard, J.T., Corboy, J.R., Cross, A.H., Dhib-Jalbut, S., Ford, C.C., Frohman, E.M., Giesser, B., Jacobs, D., Kasper, L.H., Lynch, S., Parry, G., Racke, M.K., Reder, A.T., Rose, J., Wingerchuk, D.M., MacKenzie-Graham, A.J., Arnold, D.L., Tseng, C.H., Elashoff, R., Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. The Lancet Neurology, 2015, 10.1016/S1474-4422(15)00322-1.
88. Walecki, M., Eisel, F., Klug, J., Baal, N., Paradowska-Dogan, A., Wahle, E., Hackstein, H., Meinhardt, A., Fijak, M., Androgen receptor modulates Foxp3 expression in CD4 + CD25 + Foxp3+ regulatory T-cells. Mol. Biol Cell, 2015, 10.1091/mbc.E14-08-1323.
89. Wang, C., Dehghani, B., Li, Y., Kaler, L.J., Proctor, T., Vandenbark, A.A., Offner, H., Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J. Immunol. 182 (2009), 3294–3303, 10.4049/jimmunol.0803205 (Baltimore, Md.: 1950).
90. Whitacre, C.C., Reingold, S.C., O'Looney, P.A., Blankenhorn, E., Brinley, F., Collier, E., Duquette, P., Fox, H., Giesser, B., Gilmore, W., Lahita, R., Nelson, J.L., Reiss, C., Riskind, P., Voskuhl, R.R., A gender gap in autoimmunity. Science 283 (1999), 1277–1278, 10.1126/science.283.5406.1277.
91. Wilson, M.A., Makova, K.D., Evolution and survival on eutherian sex chromosomes. PLoS Genet., 5, 2009, e1000568, 10.1371/journal.pgen.1000568.
92. Wu, W., Tan, X., Dai, Y., Krishnan, V., Warner, M., Gustafsson, J.Å., Targeting estrogen receptor beta in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 3543–3548, 10.1073/pnas.1300313110.
93. Yates, M.A., Li, Y., Chlebeck, P.J., Offner, H., GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol., 11, 2010, 20, 10.1186/1471-2172-11-20.
94. Zhang, M.A., Rego, D., Moshkova, M., Kebir, H., Chruscinski, A., Nguyen, H., Akkermann, R., Stanczyk, F.Z., Prat, A., Steinman, L., Dunn, S.E., Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 9505–9510, 10.1073/pnas.1118458109.
95. Ziehn, M.O., Avedisian, A.A., Dervin, S.M., Umeda, E.A., O'Dell, T.J., Voskuhl, R.R., Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. J. Neurosci. 32 (2012), 12312–12324, 10.1523/JNEUROSCI.2796-12.2012.